Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex

Transplantation Proceedings
A TarasewiczB Rutkowski

Abstract

Herein we have reported the use of rapamycin in immunosuppressive treatment after renal transplantation as a therapy of choice in a patient with diagnosis of tuberous sclerosis complex (TSC). TSC is a genetic disorder, caused by mutations of TSC1 or TSC2 genes. Products of these genes, hamartin and tuberin, create a complex that inhibits mammalian target of rapamycin (mTOR), a key protein engaged in regulation of the cell cycle. Mutations of TSC genes lead to constitutive activation of mTOR resulting in uncontrolled proliferation, differentiation, and migration of cells. As a consequence malformations of many organs arise. We have presented a case of a 47-year-old female TSC patient with multisystem involvement (skin, brain, lungs, and kidneys), who developed end-stage renal disease ESRD due to angiomyolipomas with subsequent bilateral nephrectomy. At the age of 44 years, she started hemodialysis treatments and 10 months later underwent kidney transplantation. Immunosuppressive treatment included the mTOR inhibitor rapamycin. Since the patient was discharged from hospital, she has remained in good clinical condition with stable graft function. Clinical evaluation after 2 years treatment with rapamycin revealed significant regre...Continue Reading

References

Mar 1, 1990·Transplantation·J L BalligandC van Ypersele de Strihou
Mar 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·F Schillinger, R Montagnac
May 18, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A ClarkeJ P Osborne
Sep 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrew R TeeJohn Blenis
Dec 11, 2003·The Journal of Urology·Toru HarabayashiTomohiko Koyanagi
Dec 20, 2003·Pediatric Neurology·Vinodh Narayanan
Oct 13, 2004·BJU International·Finbar J O'CallaghanJohn P Osborne
Apr 28, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Elizabeth Petri Henske
Jul 26, 2005·Critical Reviews in Oncology/hematology·Brian K Law
Nov 16, 2005·Transplantation·Joachim AndrassyMarkus Guba
Feb 3, 2006·Annals of Neurology·David Neal FranzKerry R Crone
Aug 26, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ralf WieneckeMatthias Kretzler
Nov 23, 2006·Transplantation Proceedings·G DallosR M Langer
Dec 2, 2006·The European Respiratory Journal·S ZarogiannisK Gourgoulianis
Jan 16, 2007·European Journal of Internal Medicine·Isabelle HerryBruno Crestani
May 2, 2007·Annals of Internal Medicine·Camille TailléBruno Crestani
Jul 20, 2007·Journal of the American Academy of Dermatology·Robert A SchwartzSergiusz Jóźwiak
Aug 25, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alf CorsencaAndreas L Serra
Jan 8, 2008·The Lancet Oncology·Jaroslaw JozwiakPawel Wlodarski
Jan 11, 2008·The New England Journal of Medicine·John J BisslerDavid N Franz
Jan 11, 2008·The New England Journal of Medicine·Elahna Paul, Elizabeth Thiele
Jan 11, 2008·The New England Journal of Medicine·D Mark DaviesJulian R Sampson
Feb 29, 2008·International Journal of Urology : Official Journal of the Japanese Urological Association·Mitsuru SaitoTomonori Habuchi
Apr 15, 2008·Lung·Dimitrios Chorianopoulos, Grigoris Stratakos
Jun 14, 2008·European Journal of Internal Medicine·Donald W HohmanSaman Ratnayake

❮ Previous
Next ❯

Citations

Feb 13, 2013·Case Reports in Transplantation·C RosadoF Vázquez-Sánchez
Mar 26, 2013·Actas dermo-sifiliográficas·R Salido-VallejoJ C Moreno-Giménez
Jul 29, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ramón PecesRafael Selgas
Oct 20, 2010·Renal Failure·Hasan MicozkadiogluIsmail Yildiz
Mar 10, 2016·Indian Journal of Dermatology·Vishalakshi ViswanathPoonam Pund
Feb 9, 2012·The Australasian Journal of Dermatology·Rachael S FosterAnne R Halbert
Aug 13, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·R SalidoJ C Moreno-Giménez
Sep 26, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·K SadowskiS Jóźwiak
Apr 28, 2010·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Tao JiangYuQi Zhang
Sep 16, 2011·Expert Review of Anticancer Therapy·David Neal Franz
Apr 8, 2017·Oxidative Medicine and Cellular Longevity·Filipe PalavraFlávio Reis
Nov 9, 2018·Journal of Nephrology·Angela VolpiMario Cozzolino
Feb 5, 2021·Proceedings of the National Academy of Sciences of the United States of America·Sharon BaroneManoocher Soleimani
Apr 7, 2021·The Journal of Dermatological Treatment·Clara Cortell FusterMónica Climente Martí

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.